|
Mechanisms of CD8 + T cell-mediated suppression of HIV/SIV replication
|
journal
|
March 2018 |
|
Modeling Deuterated Glucose Labeling of T-lymphocytes
|
journal
|
March 2002 |
|
The Disappearing CD4+T Cells in HIV Infection: a Case of Over-stimulation?
|
journal
|
April 1999 |
|
Modeling Plasma Virus Concentration during Primary HIV Infection
|
journal
|
April 2000 |
|
The Dual Role of CD4 T Helper Cells in the Infection Dynamics of HIV and Their Importance for Vaccination
|
journal
|
February 2002 |
|
Defining CTL-Induced Pathology: Implications for HIV
|
journal
|
August 2000 |
|
Estimation and Prediction With HIV-Treatment Interruption Data
|
journal
|
January 2007 |
|
Controlling IL-7 Injections in HIV-Infected Patients
|
journal
|
August 2018 |
|
HIV infection: focus on the innate immune cells
|
journal
|
September 2016 |
|
Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV
|
journal
|
October 2001 |
|
Lymphocyte kinetics: the interpretation of labelling data
|
journal
|
December 2002 |
|
Mathematical models of viral latency
|
journal
|
August 2013 |
|
Immune impairment thresholds in HIV infection
|
journal
|
April 2009 |
|
Mathematical modeling of viral kinetics under immune control during primary HIV-1 infection
|
journal
|
August 2009 |
|
Immune impairment in HIV infection: Existence of risky and immunodeficiency thresholds
|
journal
|
October 2009 |
|
Model with two types of CTL regulation and experiments on CTL dynamics
|
journal
|
April 2010 |
|
Interpreting the effect of vaccination on steady state infection in animals challenged with Simian immunodeficiency virus
|
journal
|
April 2010 |
|
Paradoxical suppression of poly-specific broadly neutralizing antibodies in the presence of strain-specific neutralizing antibodies following HIV infection
|
journal
|
May 2011 |
|
HIV evolution and progression of the infection to AIDS
|
journal
|
August 2012 |
|
Modeling interleukin-2-based immunotherapy in AIDS pathogenesis
|
journal
|
October 2013 |
|
A multi-scale mathematical modeling framework to investigate anti-viral therapeutic opportunities in targeting HIV-1 accessory proteins
|
journal
|
December 2015 |
|
T cell and reticular network co-dependence in HIV infection
|
journal
|
April 2016 |
|
Rates of HIV immune escape and reversion: implications for vaccination
|
journal
|
December 2008 |
|
Model for competition from self during passive immunization, with application to broadly neutralizing antibodies for HIV
|
journal
|
January 2012 |
|
Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection
|
journal
|
January 2014 |
|
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
|
journal
|
May 1997 |
|
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
|
journal
|
January 1999 |
|
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
|
HIV-1 adaptation to NK-cell-mediated immune pressure
|
journal
|
August 2011 |
|
Innate immunity against HIV-1 infection
|
journal
|
May 2015 |
|
A quantitative basis for antiretroviral therapy for HIV-1 infection
|
journal
|
February 2012 |
|
Immune checkpoint blockade in infectious diseases
|
journal
|
October 2017 |
|
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand
|
journal
|
June 2016 |
|
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
|
journal
|
December 2005 |
|
Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus
|
journal
|
January 2006 |
|
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
|
journal
|
March 2003 |
|
In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques
|
journal
|
April 2007 |
|
Post-treatment control of HIV infection
|
journal
|
April 2015 |
|
Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising
|
journal
|
August 2015 |
|
Nonlinear partial differential equations and applications: In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: Why are CD4+ but not CD8+ T cells depleted?
|
journal
|
November 2002 |
|
Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection
|
journal
|
July 1998 |
|
Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection
|
journal
|
February 2012 |
|
Turnover of CD4 + and CD8 + T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
|
journal
|
April 1998 |
|
Dramatic Rise in Plasma Viremia after CD8 + T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
|
journal
|
March 1999 |
|
Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy
|
journal
|
October 2001 |
|
Innate Immune Activation in Primary HIV‐1 Infection
|
journal
|
October 2010 |
|
Relative Significance of Different Pathways of Immune Reconstitution in HIV Type 1 Infection as Estimated by Mathematical Modeling
|
journal
|
January 2001 |
|
Therapeutic Vaccine Against HIV, Viral Variability, Cytotoxic T Lymphocyte Epitopes, and Genetics of Patients
|
journal
|
January 2018 |
|
Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo
|
journal
|
March 2015 |
|
Exploring the benefits of antibody immune response in HIV-1 infection using a discrete model
|
journal
|
April 2015 |
|
Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection
|
journal
|
March 2017 |
|
Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
|
journal
|
January 2000 |
|
Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation
|
journal
|
January 2003 |
|
Model of HIV-1 Disease Progression Based on Virus-Induced Lymph Node Homing and Homing-Induced Apoptosis of CD4+ Lymphocytes
|
journal
|
January 2000 |
|
Model of HIV-1 Disease Progression Based on Virus-Induced Lymph Node Homing and Homing-Induced Apoptosis of CD4+ Lymphocytes
|
journal
|
January 2000 |
|
Dynamic models of viral replication and latency
|
journal
|
January 2015 |
|
Therapeutic HIV-1 vaccine: time for immunomodulation and combinatorial strategies
|
journal
|
January 2018 |
|
Therapeutic vaccination for HIV: hopes and challenges
|
journal
|
January 2018 |
|
The role of antigenic stimulation and cytotoxic T cell activity in regulating the long–term immunopathogenesis of HIV: mechanisms and clinical implications
|
journal
|
October 2001 |
|
Estimating average cellular turnover from 5–bromo–2'–deoxyuridine (BrdU) measurements
|
journal
|
April 2003 |
|
The race between initial T–helper expansion and virus growth upon HIV infection influences polyclonality of the response and viral set–point
|
journal
|
July 2003 |
|
Integrating genealogical and dynamical modelling to infer escape and reversion rates in HIV epitopes
|
journal
|
July 2013 |
|
The challenges of modelling antibody repertoire dynamics in HIV infection
|
journal
|
September 2015 |
|
The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection
|
journal
|
September 2008 |
|
Identification and specificity of broadly neutralizing antibodies against HIV
|
journal
|
January 2017 |
|
The dynamics of simian immunodeficiency virus after depletion of CD8+ cells
|
journal
|
August 2018 |
|
Current best estimates for the average lifespans of mouse and human leukocytes: reviewing two decades of deuterium-labeling experiments
|
journal
|
August 2018 |
|
Antigenic diversity thresholds and the development of AIDS
|
journal
|
November 1991 |
|
Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response
|
journal
|
January 1996 |
|
Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells
|
journal
|
May 2016 |
|
Predicting the Impact of CD8+ T Cell Polyfunctionality on HIV Disease Progression
|
journal
|
June 2014 |
|
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
|
journal
|
August 2011 |
|
Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+ T Cells from the Dynamics of Viral Immune Escape
|
journal
|
August 2007 |
|
Cytotoxic T-Lymphocyte Escape Mutations Identified by HLA Association Favor Those Which Escape and Revert Rapidly
|
journal
|
June 2012 |
|
Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost
|
journal
|
May 2005 |
|
Naïve and Memory Cell Turnover as Drivers of CCR5-to-CXCR4 Tropism Switch in Human Immunodeficiency Virus Type 1: Implications for Therapy
|
journal
|
January 2006 |
|
Naive T-Cell Dynamics in Human Immunodeficiency Virus Type 1 Infection: Effects of Highly Active Antiretroviral Therapy Provide Insights into the Mechanisms of Naive T-Cell Depletion
|
journal
|
February 2006 |
|
Control of Human Viral Infections by Natural Killer Cells
|
journal
|
March 2013 |
|
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
journal
|
May 2016 |
|
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements
|
journal
|
April 2008 |
|
HIV-Specific Antibody Responses in HIV-Infected Patients: From a Monoclonal to a Polyclonal View
|
journal
|
January 2015 |
|
HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers
|
journal
|
August 2018 |
|
Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans
|
journal
|
September 2013 |
|
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART)
|
journal
|
January 2000 |
|
Innate immunity against HIV: a priority target for HIV prevention research
|
journal
|
October 2010 |
|
Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo
|
journal
|
March 2006 |
|
Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection
|
journal
|
March 2006 |
|
Dynamics of Immune Escape during HIV/SIV Infection
|
journal
|
July 2008 |
|
Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
|
journal
|
October 2009 |
|
Estimating the Stoichiometry of HIV Neutralization
|
journal
|
March 2010 |
|
Quantification of the Relative Importance of CTL, B Cell, NK Cell, and Target Cell Limitation in the Control of Primary SIV-Infection
|
journal
|
March 2011 |
|
The Route of HIV Escape from Immune Response Targeting Multiple Sites Is Determined by the Cost-Benefit Tradeoff of Escape Mutations
|
journal
|
October 2014 |
|
Reconciling Estimates of Cell Proliferation from Stable Isotope Labeling Experiments
|
journal
|
October 2015 |
|
Broad CTL Response in Early HIV Infection Drives Multiple Concurrent CTL Escapes
|
journal
|
October 2015 |
|
Modeling the Slow CD4+ T Cell Decline in HIV-Infected Individuals
|
journal
|
December 2015 |
|
Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection
|
journal
|
February 2016 |
|
Structured Observations Reveal Slow HIV-1 CTL Escape
|
journal
|
February 2015 |
|
Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections
|
journal
|
July 2016 |
|
Timing of Immune Escape Linked to Success or Failure of Vaccination
|
journal
|
September 2010 |
|
Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection
|
journal
|
November 2010 |
|
Biologically-Directed Modeling Reflects Cytolytic Clearance of SIV-Infected Cells In Vivo in Macaques
|
journal
|
September 2012 |
|
APOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study
|
journal
|
May 2013 |
|
Vaccination and Timing Influence SIV Immune Escape Viral Dynamics In Vivo
|
journal
|
January 2008 |
|
CD8+ T Cell Control of HIV—A Known Unknown
|
journal
|
January 2010 |
|
CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells
|
journal
|
January 2010 |
|
In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells
|
journal
|
January 2010 |
|
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
|
journal
|
March 2013 |
|
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
|
journal
|
March 2016 |
|
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters
|
journal
|
May 2017 |
|
HIV-1 adaptation to NK cell-mediated immune pressure
|
journal
|
June 2017 |
|
Pneumocystis Pneumonia—Los Angeles
|
journal
|
June 2006 |
|
The Effect of Interference on the CD8+ T Cell Escape Rates in HIV
|
journal
|
January 2015 |
|
Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics
|
journal
|
February 2018 |